This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why You Should Retain American International Stock for Now
by Zacks Equity Research
AIG remains well-poised for growth on the back of strong retention rates in the General Insurance segment. Divestitures and cost-cutting initiatives drive margins.
MetLife Expands Asset Management With $6B Acquisition From Mesirow
by Zacks Equity Research
MetLife Investment Management boosts its portfolio with a $6B acquisition from Mesirow, adding high-yield strategies, small-cap equity expertise and 20 seasoned professionals to fuel growth.
Reasons Why Investors Should Retain Principal Financial Stock Now
by Zacks Equity Research
PFG gains from strategic acquisitions, favorable growth estimates, financial stability and effective capital deployment.
Best Income Stocks to Buy for January 9th
by Zacks Equity Research
TRV, CNO and BAM made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 9, 2024.
Best Value Stocks to Buy for January 9th
by Zacks Equity Research
GIII, CNO and TRV made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 9, 2024.
Will CNO (CNO) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CNO (CNO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Best Value Stocks to Buy for January 7th
by Zacks Equity Research
FMS, SVM and CNO made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 7, 2024.
EG Stock Trading at Discount to Industry at 1.01X: Time to Hold?
by Zacks Equity Research
Everest Group remains poised to gain from strong renewal retention, continued favorable rate increases and prudent capital deployment.
Buy These 5 Insurance Stocks That Zoomed Past S&P 500 in 2024
by Sushmita Sarker
Insurance stocks MCY, ALL, CNO, PRI and UNM outperform the Zacks S&P 500 Composite and crush the market and the Finance sector.
Here's Why You Should Add CNO Financial to Your Portfolio Now
by Zacks Equity Research
CNO remains well-poised for growth on a diversified product portfolio, new product launches, technology investments and prudent capital deployment efforts.
Are Investors Undervaluing CNO Financial Group (CNO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife's Asset Management Arm Expands Reach With PineBridge Buyout
by Zacks Equity Research
MET's asset management arm is expected to close the acquisition of PineBridge by 2025, expanding its offerings and global presence.
eHealth Stock Rises 45% in a Week: Medicare Boom or AEP Magic?
by Zacks Equity Research
EHTH exceeds expectations in telephonic and online conversion rates and leverages strong consumer demand for its omnichannel platform.
Is CNO Financial Group (CNO) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how CNO Financial (CNO) and American Coastal Insurance (ACIC) have performed compared to their sector so far this year.
RDN Stock Trading at Discount to Industry at 1.02X: Time to Buy?
by Zacks Equity Research
Radian Group stock rallies on the back of an improving mortgage insurance portfolio, declining claims, a solid capital position and effective capital deployment.
Hartford Financial, Workday Unite to Enhance Employee Benefit Solutions
by Zacks Equity Research
HIG expands its partnership with Workday to enhance employee wellness solutions.
ORI Stock Trading at Discount to Industry at 1.43X: Time to Hold?
by Zacks Equity Research
Old Republic rides on high renewal retention ratios, well-performing Title business, financial flexibility, favorable growth estimates and higher return on capital.
MetLife Collaborates With General Atlantic to Launch Chariot Re
by Zacks Equity Research
MET and General Atlantic partner to launch Chariot Re, a life and annuity reinsurance company, expanding their footprint in the reinsurance space.
EVER Rallies 51.2% YTD: Time to Add the Stock for Better Returns?
by Zacks Equity Research
EverQuote stock gains from higher quote request volume, solid performance of automotive and other insurance marketplace verticals and favorable growth estimates.
BRO Rallies 53.6% YTD: Time to Buy the Stock for Solid Returns?
by Zacks Equity Research
Brown & Brown remains well-poised for growth on higher core commissions and fees, new business, solid retention, strategic acquisitions and effective capital deployment.
Why CNO Financial (CNO) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is CNO Financial Group (CNO) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AJG Rallies 35% YTD but Lags Industry: How to Play the Stock
by Zacks Equity Research
Arthur J. Gallagher gains on the back of solid performance of its Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
Synchrony Collaborates With Daybreak, Expands CareCredit Offering
by Zacks Equity Research
SYF's partnership with Daybreak is set to provide financing options for customers who want to control their sleep health.
Why Is EverQuote (EVER) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.